Latest In: David Kideckel

GW Pharmaceuticals cannabis

Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?

Jazz Pharmaceuticals' planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making…

News February 5

Image of a Welcome to New Mexico sign

New Mexico built a successful cannabis market without the hype

Image of Asian doctor holding a tablet while talking with an African American patient

Will rescheduling revive medical cannabis? It depends on the state

Image of the Drug Enforcement Administration website on a laptop

DEA registration is a tough choice for medical marijuana operators

Image of a Welcome to Illinois sign

Illinois cannabis reform bill targets licensing gap, eyes federal future

Close-up image of a female doctor's hands

CMS is setting standards for what cannabinoid medicine looks like

1

The New Genetics Race: Why Cannabis Seed Brands Are Becoming the Next Big Differentiator

The Medical Card Has a New Argument

Leveling the Legal Playing Field

Hemp’s Regulatory Reckoning: A Patchwork States Can’t Sustain

Taking Your Business to the Next Level: The Ecommerce Maturity Scale

Taking Your Business to the Next Level: The Ecommerce Maturity Scale